Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20739,845,0.99 [0.93-1.05],0.6912464661373976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20710,166,0.89 [0.77-1.03],0.1053311284811128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22419,168,0.96 [0.83-1.10],0.5599988316698219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15799,637,0.93 [0.86-1.00],0.0466479893095929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22361,110,0.85 [0.72-1.02],0.075102728598784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21470,73,0.91 [0.74-1.13],0.3894426283802805
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23563,109,0.86 [0.72-1.03],0.0934857894700825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23555,72,0.90 [0.72-1.11],0.3123456505526455
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20926,50,0.94 [0.73-1.22],0.6454754686036398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23009,103,0.98 [0.82-1.17],0.8231173313449237
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22968,62,0.87 [0.69-1.09],0.2307010068983391
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23633,67,1.01 [0.81-1.26],0.92260696956051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23606,85,1.06 [0.87-1.29],0.5356686031794199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23603,82,1.05 [0.86-1.29],0.6002002769733845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23305,58,0.96 [0.75-1.21],0.7072710371462261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22620,365,0.99 [0.90-1.08],0.773105200314305
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22368,113,1.02 [0.86-1.21],0.7980580627762957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22506,251,0.99 [0.88-1.11],0.8829855178364086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19305,46,0.82 [0.62-1.07],0.1453331248154176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19317,58,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19488,229,0.99 [0.87-1.12],0.8370398777091226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19495,236,0.98 [0.87-1.11],0.7697665640285634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19835,576,0.97 [0.90-1.05],0.4997973968976904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19305,46,1.01 [0.78-1.32],0.9184313643407744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21200,880,1.03 [0.97-1.09],0.3946713811133698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22726,254,1.08 [0.96-1.21],0.1863430503453926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23332,95,1.01 [0.83-1.21],0.9532738190920902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23716,82,1.08 [0.88-1.32],0.4473346096783617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23528,54,1.35 [1.05-1.72],0.0173751868502357
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23713,57,0.78 [0.61-0.99],0.044709815488785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,23757,43,0.81 [0.62-1.08],0.1513180726298969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23570,236,0.94 [0.83-1.06],0.2887932770338742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23715,96,0.95 [0.79-1.14],0.5935615518652371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23714,89,0.88 [0.73-1.07],0.2131658659083389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23646,63,0.92 [0.74-1.16],0.4933625467906172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",23648,62,0.94 [0.75-1.19],0.6203962415201678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,23569,233,1.10 [0.98-1.24],0.1036799852073969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23715,111,1.23 [1.04-1.45],0.0176286351043416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,23618,197,1.15 [1.01-1.30],0.0371759821087137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of breast,23700,117,0.96 [0.81-1.13],0.5955829489810291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Leiomyoma of uterus,23274,858,0.97 [0.91-1.03],0.3034327585321063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22573,234,1.02 [0.90-1.15],0.7660797007048317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22338,381,1.06 [0.97-1.17],0.1888926814723803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22338,381,1.06 [0.97-1.17],0.1888926814723803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21014,343,0.98 [0.89-1.08],0.6980394924886468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23232,84,0.78 [0.64-0.95],0.0153248104248348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23463,85,1.03 [0.85-1.26],0.7455994846189541
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19729,765,1.05 [0.98-1.13],0.1547561692417607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21792,755,1.04 [0.97-1.11],0.2811207332038299
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22160,93,0.86 [0.71-1.04],0.1269989799124667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22872,47,0.94 [0.72-1.23],0.6747145714969616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22150,83,0.92 [0.76-1.13],0.4370677516864301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22416,349,1.04 [0.94-1.15],0.5055877327872582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22406,339,1.04 [0.94-1.16],0.4168788900113751
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22003,161,0.96 [0.82-1.13],0.6189088361559132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22005,158,0.97 [0.83-1.14],0.7376597199310279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19560,596,1.04 [0.96-1.12],0.3358350792480861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19031,67,1.11 [0.89-1.38],0.3672979312264961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19517,553,1.03 [0.95-1.12],0.405879487080228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19011,47,1.13 [0.87-1.48],0.3547862039036871
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19022,58,0.99 [0.78-1.26],0.9478765554882538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,20037,524,1.01 [0.93-1.10],0.793959279278457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19612,99,0.92 [0.77-1.11],0.4054630415437384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23537,63,0.87 [0.69-1.09],0.2254631565503332
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23574,38,0.78 [0.58-1.06],0.110231409931298
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22500,31,1.00 [0.72-1.39],0.9901049222403236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23711,31,1.00 [0.72-1.38],0.9937353668894204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19544,31,1.01 [0.73-1.39],0.9721012105753584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,22492,23,0.76 [0.52-1.13],0.1758067520738828
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,22415,32,0.88 [0.63-1.23],0.4493150093212611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19551,38,0.97 [0.72-1.30],0.8268579840638506
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19833,320,1.01 [0.91-1.12],0.7947499789333532
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Depression,22019,285,0.98 [0.88-1.10],0.7605157023665858
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,19651,247,1.03 [0.91-1.15],0.6427212758139207
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19645,132,1.08 [0.92-1.26],0.3621270150311888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22109,67,0.89 [0.71-1.12],0.3135710843974448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,20562,1403,1.01 [0.96-1.06],0.8300943579837585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18810,169,0.98 [0.85-1.13],0.7701919667135055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23584,138,0.98 [0.84-1.14],0.7775064687096891
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22632,362,1.00 [0.91-1.10],0.9710084045809771
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22383,113,1.05 [0.88-1.24],0.5935338668508983
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,22378,108,1.14 [0.96-1.35],0.1482089269278067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23375,100,1.13 [0.94-1.35],0.1969376913235014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23155,51,1.04 [0.81-1.34],0.7564482535937607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22357,87,0.84 [0.69-1.03],0.0905807386837265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23406,63,0.91 [0.72-1.14],0.4075025796497458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22566,725,1.00 [0.93-1.07],0.9010225201356352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21945,104,1.03 [0.86-1.23],0.7284464519272869
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22296,455,1.02 [0.94-1.11],0.6514959909606366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23537,67,1.14 [0.92-1.42],0.2325558702946192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23521,51,1.12 [0.87-1.44],0.3643390915627538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23337,104,0.91 [0.76-1.08],0.2757987555319803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23124,370,1.00 [0.91-1.10],0.9762201927273418
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22967,213,1.09 [0.96-1.24],0.1716995331213869
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22818,64,0.83 [0.66-1.04],0.0970365403800333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22869,115,1.13 [0.95-1.34],0.1632098320815724
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22844,90,1.11 [0.92-1.34],0.2837215344826916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20144,150,0.97 [0.83-1.12],0.6541725519841022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20350,356,1.01 [0.92-1.12],0.8104779822468654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22862,153,1.01 [0.87-1.17],0.935721506645818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23534,29,0.87 [0.62-1.22],0.4178876077150768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1535,29,0.89 [0.63-1.26],0.5082984157825852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22028,29,0.87 [0.62-1.22],0.4250396884784508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23153,81,1.05 [0.86-1.29],0.615885664316343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23116,44,1.15 [0.87-1.51],0.324164730496821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23025,79,0.94 [0.77-1.16],0.5701681973496663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23251,89,0.94 [0.78-1.14],0.537816326742078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23648,106,1.02 [0.86-1.22],0.8090784331903154
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23070,95,0.99 [0.82-1.19],0.903930221960642
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17458,2373,1.02 [0.98-1.06],0.3977527546408377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23266,69,0.94 [0.75-1.17],0.5635331913187509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18368,1735,1.03 [0.98-1.08],0.2956529327746047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,18384,1751,1.02 [0.97-1.08],0.3436396002934185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16667,34,0.93 [0.68-1.27],0.6348203894793518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22308,613,1.01 [0.94-1.09],0.7399981327495804
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22119,424,1.00 [0.91-1.10],0.9928339533213776
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23184,122,0.92 [0.78-1.09],0.3412578479598191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23251,189,0.98 [0.86-1.12],0.7742038671904572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23695,25,1.04 [0.72-1.50],0.8308609690488615
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21774,79,1.04 [0.84-1.28],0.7161860820888539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22080,396,1.03 [0.94-1.14],0.4923158028996133
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23065,86,1.15 [0.95-1.40],0.1569668683522063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23166,185,1.10 [0.96-1.26],0.1603057341995127
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23069,90,0.88 [0.73-1.07],0.1973193633637404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23069,90,0.88 [0.73-1.07],0.1973193633637404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16720,87,0.90 [0.74-1.10],0.3006221475317427
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20657,33,1.12 [0.81-1.54],0.5002491044751516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,20688,64,1.16 [0.93-1.46],0.1923153347697254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14262,85,1.04 [0.85-1.27],0.7039407422522821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14412,235,0.96 [0.85-1.09],0.5150262796402412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20667,43,0.99 [0.75-1.31],0.9313850279110472
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20672,48,1.03 [0.79-1.34],0.8302134450021806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23048,88,1.14 [0.94-1.39],0.185366110839225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23082,114,1.01 [0.85-1.19],0.9487333888781718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23117,85,1.06 [0.87-1.29],0.5930671122810499
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23177,73,1.07 [0.87-1.33],0.523845070405123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22896,60,0.86 [0.68-1.09],0.219002873368972
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22928,92,0.88 [0.73-1.06],0.1749613987597795
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22372,110,1.11 [0.94-1.33],0.2238042810042513
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22350,88,1.15 [0.95-1.40],0.1493795051690306
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23566,87,1.15 [0.95-1.40],0.1600677000398852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,22792,530,0.92 [0.85-0.99],0.0298813927184122
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,22801,73,0.98 [0.79-1.21],0.8214255098345545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19299,1822,1.01 [0.96-1.05],0.7825142930268215
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23564,108,0.99 [0.83-1.18],0.923013407135734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22350,176,0.96 [0.84-1.10],0.561386758808661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22334,160,0.99 [0.86-1.15],0.9236039655024312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22969,200,0.98 [0.87-1.12],0.8168990563963225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22965,196,0.99 [0.87-1.13],0.9059040885684364
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23088,486,1.04 [0.96-1.13],0.3328967284975924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22706,104,1.11 [0.93-1.33],0.2436765989453966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22673,71,1.14 [0.92-1.41],0.2380690133762124
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22909,307,1.04 [0.93-1.15],0.4981015734717232
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22723,121,1.01 [0.86-1.19],0.8878576807659492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11399,55,1.09 [0.85-1.39],0.502063341721919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21180,1000,1.00 [0.94-1.06],0.972391100285734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,22858,135,1.10 [0.94-1.29],0.2378043848169168
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22875,152,1.02 [0.88-1.19],0.7924052227965231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22875,152,1.02 [0.88-1.19],0.7924052227965231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21950,859,1.01 [0.94-1.07],0.8550835537654125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Asthma,17629,859,1.01 [0.94-1.07],0.8633362501739439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17470,859,1.01 [0.94-1.07],0.8656442507395559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17617,847,1.00 [0.94-1.07],0.9988990501904158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23473,77,0.92 [0.75-1.14],0.4557990913532441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22165,58,0.88 [0.69-1.12],0.2958821192618187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23535,58,0.88 [0.70-1.12],0.3115128421874128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22159,52,0.86 [0.67-1.11],0.2473773607926436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,22158,73,0.95 [0.77-1.18],0.6554305004383543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22253,168,0.98 [0.86-1.13],0.8242085716312302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22741,82,0.93 [0.76-1.14],0.5074107974190785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16480,5182,0.99 [0.96-1.02],0.5286789456279735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23254,408,1.08 [0.98-1.18],0.1050036677998699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23717,86,1.12 [0.93-1.36],0.2398189851485112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,23722,78,1.15 [0.94-1.40],0.1878797374686226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,22940,94,1.06 [0.88-1.28],0.5333181438192478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22954,108,1.16 [0.97-1.38],0.0998157924619131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23708,96,1.12 [0.93-1.35],0.2223992392661793
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22943,97,1.11 [0.93-1.34],0.2565700250401325
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22689,68,0.84 [0.67-1.05],0.1177369876079127
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23633,43,0.85 [0.64-1.12],0.2358388747472453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17954,191,0.92 [0.81-1.05],0.225042650893382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19764,2001,0.99 [0.95-1.04],0.7357726403741924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,18018,255,1.16 [1.04-1.31],0.0092506431464952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18409,646,1.02 [0.94-1.09],0.658753048172011
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17830,67,1.09 [0.88-1.36],0.4314589424737877
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17881,118,1.18 [1.00-1.40],0.0484992578565162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17796,33,1.22 [0.89-1.67],0.2270389905938274
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17890,127,0.87 [0.74-1.02],0.0843149596295825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17828,65,1.01 [0.80-1.27],0.937956460942192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23675,51,0.94 [0.73-1.22],0.6492114202622044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17877,114,0.97 [0.81-1.15],0.6847851771935103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18493,730,0.98 [0.91-1.05],0.4910232585136211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23613,133,1.03 [0.88-1.20],0.7484784242378144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18259,496,1.00 [0.92-1.08],0.9278989920865643
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17913,150,0.96 [0.83-1.12],0.6239245794576613
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23631,123,0.94 [0.80-1.11],0.4960373390739616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23590,110,0.98 [0.82-1.16],0.7885535240340323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,21270,1041,1.01 [0.95-1.07],0.7677844202802755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20287,58,0.87 [0.69-1.11],0.2556475283533843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20296,67,1.12 [0.89-1.40],0.3415347291848062
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20319,90,1.00 [0.83-1.22],0.9765712824892392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21061,832,1.02 [0.95-1.09],0.5646251400508954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22824,791,0.97 [0.91-1.04],0.3592734465284013
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18832,1885,1.00 [0.95-1.04],0.8793917188473638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23458,58,0.86 [0.68-1.09],0.2248544881572685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23697,82,0.93 [0.76-1.14],0.4992818361235114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,22115,82,0.94 [0.77-1.14],0.5115577272531691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22093,60,0.84 [0.67-1.06],0.1464900559951789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23623,112,1.09 [0.92-1.29],0.3322541310894431
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22145,112,1.09 [0.92-1.29],0.3349085113629607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22131,98,1.07 [0.89-1.29],0.440950089260254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22706,673,0.97 [0.90-1.04],0.3532787608699107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22696,663,0.97 [0.90-1.04],0.3415952500956545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17035,88,1.05 [0.87-1.28],0.5931405423022452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23341,88,1.06 [0.87-1.28],0.5791011006901452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17001,54,1.02 [0.80-1.31],0.8467309106917301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17532,585,0.94 [0.87-1.02],0.1498428829941998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17157,210,1.00 [0.88-1.13],0.9398411143739408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17278,331,1.01 [0.91-1.12],0.8533121403555349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,22297,296,1.01 [0.91-1.12],0.8597322654061476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23304,112,0.92 [0.77-1.09],0.3290108587976985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17056,109,0.99 [0.83-1.17],0.887855278272646
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16987,40,0.88 [0.66-1.17],0.3912789617093617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17721,774,1.01 [0.94-1.08],0.7925961072252242
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,17147,200,0.92 [0.81-1.05],0.2020961602376663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23290,98,0.91 [0.76-1.09],0.3038106357027984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,23077,89,0.78 [0.64-0.95],0.0130625447975137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23035,47,0.83 [0.64-1.09],0.1830136576351159
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22383,738,1.00 [0.94-1.08],0.8915267923754436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22262,617,1.00 [0.93-1.08],0.9797394153151582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,21755,110,1.08 [0.90-1.28],0.4120606123535411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21702,57,1.08 [0.85-1.37],0.5243093342672227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21695,50,0.86 [0.66-1.12],0.2548400914902075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23613,50,0.85 [0.66-1.11],0.2408496472981697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22572,252,1.11 [0.99-1.25],0.0693200905742352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22405,85,1.13 [0.93-1.37],0.2343583093894964
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22395,75,1.13 [0.92-1.39],0.2368638666973298
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22353,33,1.15 [0.84-1.57],0.393459032408879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22459,139,1.16 [0.99-1.35],0.0607287135580772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,22451,131,1.17 [1.00-1.37],0.052173992556723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21026,1391,0.94 [0.89-0.99],0.0177549872586342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23359,101,0.85 [0.71-1.02],0.0744313058775008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23365,396,0.97 [0.89-1.07],0.5471390836679952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22381,586,0.97 [0.90-1.05],0.4724742083545734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23034,286,0.92 [0.83-1.03],0.1358388099734488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22812,64,0.88 [0.70-1.11],0.2842365391576833
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22933,185,0.90 [0.78-1.03],0.1246104013038495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23494,77,0.82 [0.66-1.01],0.0607904394860022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23473,56,0.80 [0.63-1.03],0.0824378685390641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23460,43,0.78 [0.59-1.03],0.0757041461707765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23528,50,1.03 [0.80-1.33],0.810554196348485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23525,47,1.03 [0.79-1.34],0.8483958322579426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23022,53,1.09 [0.85-1.41],0.4810914363894311
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23275,306,0.97 [0.88-1.08],0.6126191849804383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21875,80,0.90 [0.74-1.11],0.3346072574885647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21921,126,0.92 [0.78-1.08],0.3172881614245978
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21886,91,0.93 [0.77-1.13],0.4563157362260864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22020,225,1.04 [0.92-1.17],0.5176013253381355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21998,203,1.03 [0.91-1.17],0.619629223303024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16704,3803,1.00 [0.96-1.03],0.8980967584388364
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18229,2177,1.03 [0.98-1.07],0.2468769243936199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21317,1156,1.05 [0.99-1.11],0.0898172640608998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16238,186,1.00 [0.87-1.14],0.9903605158719306
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16497,445,0.98 [0.90-1.07],0.624655322839815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23251,178,1.02 [0.89-1.16],0.8254622596599046
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23266,163,0.99 [0.86-1.14],0.8998315329482227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17105,1053,1.05 [0.98-1.11],0.1426760581809461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19435,1053,1.05 [0.99-1.11],0.1169401221027282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16063,11,0.72 [0.40-1.28],0.2641445249906637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23592,11,0.68 [0.38-1.21],0.1905317162516016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16283,231,0.98 [0.87-1.11],0.7201223438192239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16126,74,0.94 [0.76-1.16],0.5552205698010559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16323,271,1.09 [0.97-1.22],0.1491797748329136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23572,144,1.18 [1.01-1.37],0.0332353262118741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16459,407,1.08 [0.98-1.18],0.1332373833569325
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16461,409,1.01 [0.92-1.10],0.8976779152560352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17264,1212,1.02 [0.96-1.07],0.5902873480741369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16149,97,1.16 [0.97-1.40],0.1102132256906252
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16407,355,0.96 [0.87-1.06],0.4345864017044254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16119,67,1.02 [0.81-1.28],0.8640913406259624
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16143,91,1.01 [0.83-1.22],0.9393575083908028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16367,315,1.06 [0.95-1.17],0.2853158190162567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16320,268,1.07 [0.96-1.20],0.2462425051495876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17679,258,0.99 [0.89-1.11],0.8933703250786778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23021,209,0.93 [0.82-1.06],0.2792778580904301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22894,82,1.02 [0.83-1.24],0.8633136819743474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20325,74,0.93 [0.75-1.15],0.4891922999557616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20518,267,0.90 [0.80-1.01],0.0654177857237716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21151,900,0.92 [0.86-0.98],0.0079603915021347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20437,186,0.91 [0.79-1.04],0.1620501678043775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20320,69,0.96 [0.77-1.20],0.7352347237205927
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20971,720,0.92 [0.86-0.99],0.0261664237120605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20294,43,1.23 [0.93-1.62],0.1441041043744513
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20466,215,0.90 [0.80-1.02],0.1085597624328283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20340,89,0.93 [0.76-1.12],0.440293560297919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20328,77,0.93 [0.76-1.15],0.5183894349825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20382,131,0.85 [0.72-0.99],0.0414887175329691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20322,71,1.00 [0.81-1.24],0.99662977575508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20563,312,0.99 [0.89-1.10],0.8447945898261966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20496,335,1.02 [0.92-1.13],0.7069154066394885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20224,63,0.92 [0.73-1.16],0.4905153065877857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20258,97,0.87 [0.72-1.04],0.1292319440419626
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20281,120,1.26 [1.07-1.48],0.00597748866914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20197,36,0.97 [0.72-1.31],0.8428084552366829
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20210,49,1.11 [0.86-1.44],0.4155433027380412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20198,37,1.06 [0.78-1.42],0.7158348315095893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20393,232,1.03 [0.92-1.17],0.5816491298055794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20212,51,1.01 [0.78-1.30],0.947287961058714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20217,56,0.98 [0.77-1.26],0.8985110737351768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20277,116,1.12 [0.95-1.33],0.1714845552381146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20233,72,1.10 [0.89-1.36],0.3867907685799151
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20634,473,1.04 [0.96-1.14],0.3117276713869978
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20327,166,0.96 [0.84-1.11],0.6048075723718584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20418,257,1.04 [0.93-1.17],0.4964086154313744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21371,212,0.92 [0.81-1.04],0.1784445616688493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21574,415,0.89 [0.82-0.98],0.0156732232001554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21192,33,1.00 [0.73-1.37],0.992297963671899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21209,50,0.87 [0.67-1.13],0.2893774520700592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21251,92,0.84 [0.69-1.01],0.0670976801309116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19467,5294,0.97 [0.94-1.00],0.0302171167035116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21745,152,0.98 [0.85-1.14],0.8370823139752342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21631,38,1.18 [0.88-1.57],0.2740298173297872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21916,26,1.12 [0.79-1.60],0.5161934423631084
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21921,31,0.88 [0.64-1.22],0.4490628658012194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21919,29,0.99 [0.71-1.39],0.9756770541977952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23544,110,0.91 [0.77-1.09],0.3006048740921002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23447,54,0.99 [0.77-1.27],0.9479766583690532
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23517,83,0.91 [0.74-1.11],0.3501591027143838
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23465,31,0.94 [0.68-1.30],0.7305656724414393
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21848,1075,1.01 [0.95-1.07],0.8287204302777734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20878,105,0.97 [0.81-1.15],0.7000418994196509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20846,73,1.07 [0.87-1.32],0.5191541320969888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20912,139,0.97 [0.83-1.13],0.6667512132516074
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20853,80,0.84 [0.68-1.02],0.0851675325629837
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21623,850,1.03 [0.96-1.09],0.414854392502237
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23488,420,0.89 [0.81-0.97],0.0105206746118579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23200,132,0.85 [0.73-1.00],0.0496791691901533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23211,143,0.96 [0.82-1.11],0.577401324389966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23171,103,0.86 [0.72-1.03],0.0978028132818188
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23425,479,1.01 [0.93-1.09],0.8911436587065791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23061,115,0.96 [0.81-1.14],0.6567972191560558
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23160,214,1.00 [0.89-1.14],0.9515788464733156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21658,3972,0.98 [0.95-1.01],0.2630730021945827
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17994,308,1.07 [0.96-1.19],0.2008126032499205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17772,86,1.34 [1.10-1.63],0.0030001044519629
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17830,144,1.04 [0.89-1.21],0.6374007514483278
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18376,690,1.03 [0.96-1.10],0.4679060130940842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18036,350,0.97 [0.88-1.07],0.4969702083808524
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18510,824,0.94 [0.88-1.00],0.0579696035070331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17956,270,0.84 [0.75-0.94],0.0022110280348376
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18063,377,0.98 [0.89-1.07],0.6320706075020773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17773,87,1.15 [0.95-1.39],0.166068242713461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17855,169,1.11 [0.97-1.27],0.1425989441766516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23718,232,1.09 [0.97-1.23],0.1402440795680219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23727,220,1.09 [0.97-1.23],0.1525061036030482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23748,119,1.13 [0.96-1.33],0.1419692718496891
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23740,131,1.12 [0.96-1.31],0.1484389498295387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17815,129,0.98 [0.84-1.15],0.823003635960252
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17788,102,0.93 [0.78-1.12],0.455557812850396
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17810,124,1.04 [0.88-1.22],0.6607267421874444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23659,405,1.06 [0.97-1.16],0.2310509521870773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18849,1163,1.00 [0.95-1.06],0.8777753817313784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18445,759,0.98 [0.92-1.05],0.6591366537918999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23735,176,0.97 [0.85-1.11],0.6589704489798838
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18088,402,0.95 [0.86-1.04],0.2364576222051688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17957,271,0.96 [0.86-1.08],0.5216904602519392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18471,785,0.95 [0.89-1.01],0.1111068611632826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female infertility,17770,84,1.15 [0.94-1.41],0.1649519963964496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17763,77,1.16 [0.94-1.42],0.1676918425930735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23743,724,1.07 [1.00-1.15],0.0637031499316982
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23749,1001,1.09 [1.02-1.17],0.0079301083251574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23743,384,1.08 [0.98-1.18],0.1364740418712114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23465,106,1.15 [0.97-1.37],0.1119881909478552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23514,155,1.01 [0.87-1.17],0.8757762766420282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23497,138,1.13 [0.96-1.32],0.1329710248428401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23760,141,1.04 [0.89-1.22],0.6111979804882222
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23762,139,1.05 [0.90-1.22],0.5696169559265434
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23760,359,1.01 [0.91-1.11],0.866049688618374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23508,107,0.85 [0.71-1.01],0.0722149568591295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23602,201,1.06 [0.93-1.21],0.3780617355568015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23141,122,1.12 [0.95-1.33],0.1709371133645695
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23187,168,1.11 [0.96-1.28],0.1629091642415734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23221,202,1.05 [0.92-1.20],0.4397022523282793
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23143,124,1.09 [0.92-1.28],0.3311550588076372
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23132,113,1.10 [0.93-1.31],0.2752614768845752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23144,125,0.95 [0.80-1.12],0.5479468502754921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22937,189,1.17 [1.02-1.33],0.0238150406497723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23120,372,1.05 [0.95-1.16],0.3155770981720058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23297,549,1.13 [1.04-1.23],0.0033021455857002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23764,148,1.08 [0.93-1.25],0.3334961142677478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22558,113,1.06 [0.89-1.26],0.4953313043722885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22832,84,0.99 [0.81-1.21],0.9086330877182712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23770,282,0.96 [0.86-1.08],0.5242318469112253
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23706,218,0.98 [0.86-1.11],0.7244442704907073
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23759,212,1.04 [0.92-1.18],0.5193613176755594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23749,202,1.03 [0.90-1.17],0.6902960591386287
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23504,42,0.87 [0.66-1.16],0.3404674560650779
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21265,538,0.91 [0.84-0.99],0.0255548511095418
